Susmed Inc. (Headquarters: Chuo-ku, Tokyo; President and CEO: Taro Ueno; hereinafter referred to as "the Company") is pleased to announce the launch of a new website, "Nemuri no Michishirube" (hereinafter referred to as "this Site"), to provide accurate knowledge about insomnia and its treatments.

According to a survey by the Ministry of Health, Labour and Welfare, approximately one in five adults in Japan do not get enough rest from sleep, indicating that insomnia is one of the modern diseases faced by many people. Prolonged insomnia is known to not only reduce the quality of daily life (QOL) but also carry the risk of various physical illnesses.

The Company is a research and development-oriented company promoting digital health, and is developing and providing therapeutic applications (DTx: Digital Therapeutics) as a new option for insomnia. We believe that correct understanding of the disease and promotion of early consultation are crucial not only for individual health issues but also from the perspective of overall societal sustainability and economic activity. With this in mind, we have launched this Site with the aim of deepening the understanding of the disease and its treatments for those who suffer from daily sleep problems and insomnia.

"Nemuri no Michishirube" URL: https://sleep.susmed.co.jp/

The Company will actively disseminate reliable information in an easy-to-understand manner to resolve the daily anxieties and health challenges of patients suffering from insomnia.

<About Susmed Inc.>

Susmed Inc. is a research and development-oriented company promoting digital health, engaged in the development and provision of medical applications, including an application for insomnia disorder. The company also holds patented technologies such as blockchain technology, which leads to the efficiency of clinical trials, and AI automatic analysis technology, which is expected to improve data analysis efficiency and reduce costs. Susmed Inc. develops and provides clinical development support systems utilizing these technologies.

URL: https://www.susmed.co.jp/

<Inquiries regarding this release>

https://www.susmed.co.jp/contact/

<Inquiries from medical institutions and healthcare professionals>

https://www.susmed.co.jp/contact/medical/

FACT BOX

  • Source: PR TIMES
  • Category: 企業発表